PMS2 and colorectal carcinoma: Patients with MLH1 and MSH2 germline pathogenic variants (PVs) or likely pathogenic variants (LPVs) have an increased risk of developing colorectal cancer (CRC) and endometrial cancer (EC) compared to patients with MSH6 or PMS2 germline PVs/LPVs [3].